Literature DB >> 10881978

Nosological implications of psychotic symptoms in patients with established posttraumatic stress disorder.

A O Chan1, D Silove.   

Abstract

OBJECTIVE: We describe three patients with chronic posttraumatic stress disorder (PTSD) who later developed psychotic symptoms. The nosological implications are discussed. CLINICAL PICTURE: All three patients had no prior history of psychotic illness. The content of the psychotic symptoms was restricted to core features of the traumatic experiences which initially led to PTSD. TREATMENT: The patients received low-dose antipsychotic medications in addition to other treatments for PTSD and/or depression. OUTCOME: All three patients developed severe extrapyramidal side effects, particularly akathisia, and discontinued drug treatment.
CONCLUSION: Psychotic symptoms occasionally can complicate chronic PTSD, but uncertainty remains about their aetiology and nosological status.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10881978     DOI: 10.1080/j.1440-1614.2000.00723.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  4 in total

1.  Pharmacotherapy of treatment-resistant combat-related posttraumatic stress disorder with psychotic features.

Authors:  Nela Pivac; Dragica Kozarić-Kovacić
Journal:  Croat Med J       Date:  2006-06       Impact factor: 1.351

2.  Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related post-traumatic stress disorder.

Authors:  Nela Pivac; Dragica Kozaric-Kovacic; Dorotea Muck-Seler
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

3.  A diagnostic dilemma between psychosis and post-traumatic stress disorder: a case report and review of the literature.

Authors:  Ricardo Coentre; Paddy Power
Journal:  J Med Case Rep       Date:  2011-03-10

4.  Trauma exposure, PTSD and psychotic-like symptoms in post-conflict Timor Leste: an epidemiological survey.

Authors:  Ian Soosay; Derrick Silove; Catherine Bateman-Steel; Zachary Steel; Paul Bebbington; Peter B Jones; Tien Chey; Lorraine Ivancic; Claire Marnane
Journal:  BMC Psychiatry       Date:  2012-12-18       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.